Form 4: Director Dorothy Puhy Increases Stake in MiMedx Group

Director Dorothy Puhy acquired 50,913 shares of MiMedx Group common stock as part of an annual restricted stock grant.

Summary

• Director Dorothy Puhy received an annual restricted stock grant of 50,913 shares of MiMedx Group (MDXG) common stock.
• The transaction occurred on June 10, 2026, at a price of $3.64 per share.
• Following this transaction, Puhy's total beneficial ownership increased to 108,510 shares.
• The award is subject to vesting on the earlier of 12 months or the next annual meeting of shareholders.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that does not signal a change in company strategy or financial health.

Positives

• Director alignment with shareholder interests is strengthened through increased equity ownership.
• The grant represents standard compensation for non-employee directors, indicating stable corporate governance practices.

Negatives

• None identified; this is a routine compensatory equity grant.

Risks

• The value of the equity grant is subject to market volatility and the future performance of MiMedx Group stock.

Future Outlook

The restricted stock grant vests on the earlier of 12 months from the grant date or the next meeting of shareholders, aligning the director's interests with the company's performance over the coming year.

Management Comments

• The grant is an annual restricted stock award for non-employee directors, exempt under Rule 16b-3.

Industry Context

StockSavvy.ai notes that routine equity grants to board members are standard industry practice for public companies to ensure long-term alignment between leadership and shareholders, and this filing reflects typical corporate governance activity.

Comparison to Industry Standards

• The grant structure is consistent with standard compensation packages for independent directors in the biotechnology and medical device sectors.
• The vesting period of 12 months is a common benchmark for director equity compensation.

Corporate Governance

Stakeholder Impact

• Shareholders: Positive signal of director commitment to the company's long-term success.

Next Steps

• Vesting of the 50,913 shares in 12 months or at the next shareholder meeting.

Key Dates

Keywords

MiMedx, MDXG, Director, Insider Trading, Equity Grant, Form 4